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Homoserine and quorum-sensing acyl homoserine lactones
as alternative sources of threonine: a potential role for
homoserine kinase in insect-stage Trypanosoma brucei
Han B. Ong, Wai S. Lee,† Stephen Patterson,
Susan Wyllie and Alan H. Fairlamb*
Division of Biological Chemistry & Drug Discovery,
College of Life Sciences, University of Dundee, Dundee
DD1 5EH, UK.
Summary
De novo synthesis of threonine from aspartate occurs
via the β-aspartyl phosphate pathway in plants, bacte-
ria and fungi. However, the Trypanosoma brucei
genome encodes only the last two steps in this
pathway: homoserine kinase (HSK) and threonine syn-
thase. Here, we investigated the possible roles for this
incomplete pathway through biochemical, genetic and
nutritional studies. Purified recombinant TbHSK spe-
cifically phosphorylates L-homoserine and displays
kinetic properties similar to other HSKs. HSK null
mutants generated in bloodstream forms displayed no
growth phenotype in vitro or loss of virulence in vivo.
However, following transformation into procyclic
forms, homoserine, homoserine lactone and certain
acyl homoserine lactones (AHLs) were found to sub-
stitute for threonine in growth media for wild-type
procyclics, but not HSK null mutants. The tsetse fly is
considered to be an unlikely source of these nutrients
as it feeds exclusively on mammalian blood. Bioinfor-
matic studies predict that tsetse endosymbionts
possess part (up to homoserine in Wigglesworthia
glossinidia) or all of the β-aspartyl phosphate pathway
(Sodalis glossinidius). In addition S. glossinidius is
known to produce 3-oxohexanoylhomoserine lactone
which also supports trypanosome growth. We
propose that T. brucei has retained HSK and threonine
synthase in order to salvage these nutrients when
threonine availability is limiting.
Introduction
Human African trypanosomiasis (African sleeping sick-
ness), a disease caused by two subspecies of the proto-
zoan parasite Trypanosoma brucei (T. b. gambiense and
T. b. rhodesiense), is estimated to kill ∼ 10 000 people in
sub-Saharan Africa every year (Aksoy, 2011). A third sub-
species, T. b. brucei, which is non-pathogenic to humans,
but causes the economically important cattle disease
nagana, is widely used as a model organism for the human
disease (Sokolova et al., 2010). T. brucei infection is trans-
mitted between mammalian hosts via the bite of an infected
tsetse fly (Glossina spp.), an obligate blood feeder. These
parasites undergo marked biological and biochemical
changes during their life cycle, alternating predominantly
between the bloodstream and procyclic trypomastigote
forms in the mammalian bloodstream and tsetse mid-gut
respectively (Jones et al., 2014).
Current drugs (suramin, pentamidine, melarsoprol and
nifurtimox-eflornithine combination therapy) used to treat
African sleeping sickness are far from ideal in terms
of efficacy, safety and cost (Fairlamb, 2003; Stuart
et al., 2008). Programmes coordinated by the Drugs for
Neglected Diseases initiative (DNDi) have identified two
promising candidates (the nitro-drug fexinidazole and the
oxaborole SCYX-7158), both of which are currently in
clinical development (Barrett, 2010; Nare et al., 2010;
Maser et al., 2012). However, given the high attrition rate in
drug discovery, additional potential druggable targets or
pathways are required.
One such pathway is the β-aspartyl phosphate pathway
found in plants, fungi and bacteria, where aspartate is the
precursor for the synthesis of lysine, threonine, methionine
and isoleucine (Azevedo et al., 2006). This pathway is
absent in mammals, and thus these essential amino acids
have to be obtained from the diet. The de novo biosynthe-
sis of threonine from aspartate involves the key intermedi-
ate homoserine (Fig. 1). Homoserine is produced from the
sequential phosphorylation of aspartate by aspartokinase
(EC 2.7.2.4), followed by the reduction of aspartyl-4-
phosphate and aspartate semialdehyde intermediates by
aspartate semialdehyde dehydrogenase (EC 1.2.1.11) and
homoserine dehydrogenase (EC 1.1.1.3) respectively.
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Homoserine kinase (HSK, EC 2.7.1.39) then converts
homoserine to O-phospho-homoserine, which is subse-
quently metabolised to threonine by threonine synthase
(ThrS, EC 4.2.3.1). HSKs are part of the GHMP kinase
superfamily that also includes galactokinases, mevalonate
kinases and phosphomevalonate kinases. In Candida
albicans, HSK mutants are hypersensitive to the toxic
effects of homoserine and show attenuated virulence in
mice (Kingsbury and McCusker, 2010a,b). In the case of
another fungal pathogen, Cryptococcus neoformans, the
threonine biosynthetic pathway is essential (Kingsbury and
McCusker, 2008). Thus, HSK is an attractive potential
target for drug discovery of novel antifungal compounds
(De Pascale et al., 2011).
Threonine metabolism is particularly important in African
trypanosomes because bloodstream forms preferentially
use this amino acid as the major source of acetyl coen-
zyme A for lipid biosynthesis (Cross et al., 1975; Gilbert
et al., 1983). Although they can salvage threonine from the
medium (Voorheis, 1977), it is not known if these parasites
can also synthesise it de novo. A 13C-tracer study demon-
strated that aspartate can be efficiently converted to threo-
nine in the related trypanosomatid, Leishmania mexicana,
via the β-aspartyl phosphate pathway (Saunders et al.,
2011). Candidate genes for the pathway have been pro-
posed (Fig. 1), including aspartokinase, the first enzyme in
the pathway, but none of these have been characterised in
trypanosomatids. In contrast, only HSK (Tb927.6.4430)
and ThrS (Tb927.7.4390) have been identified in the
T. brucei genome, and our bioinformatic studies failed to
identify any credible candidates for the conversion of
aspartate to homoserine.
In the current study, we have used a combination of
biochemical and genetic techniques to address a number
of questions: does Tb927.6.4430 encode a bona fide
HSK; is it essential and thus a drug target; where is
homoserine derived from; and why would this parasite
retain only part of the β-aspartyl phosphate pathway? We
provide evidence to suggest that HSK may be important
for growth of the insect-stage of the life cycle in which
bacterial quorum-sensing molecules produced by a tsetse
fly endosymbiont may provide a source of homoserine for
threonine biosynthesis.
Results
Cloning and sequencing of TbHSK
An alignment of HSK sequences from the T. brucei
genome strain 927 with representatives from other
species is presented in Fig. 2. Key residues identified from
structural studies on the Methanococcus jannaschii
enzyme that are involved in substrate recognition are
highlighted (Zhou et al., 2000; Krishna et al., 2001).
Although the sequence identity between T. brucei and M.
jannaschii is low (21%), all five amino acid side chains
Fig. 1. De novo threonine biosynthesis
pathway. Aspartate is sequentially converted
to homoserine via a series of enzymatic
reactions involving aspartokinase (AspK),
aspartate semialdehyde dehydrogenase
(AspSD) and homoserine dehydrogenase
(HSD). Homoserine is phosphorylated by HSK
to form O-phospho-homoserine, a substrate
for threonine synthase (ThrS) to produce
threonine. Candidate genes for each of these
metabolic enzymes are shown for
Trypanosoma brucei and Leishmania major.
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interacting with homoserine are strictly conserved (high-
lighted in blue). Significant conservation of the phosphate-
binding loop interacting with adenosine triphosphate
(ATP) is also evident (yellow), as are two residues in a
helix (residues 181–189 in M. jannaschii) that undergo
pronounced conformational changes upon binding of
homoserine, shielding the HSK ternary complex from
solvent (green). Another highly conserved loop (residues
259–264 in M. jannaschii) is thought to play a role in
stabilising the phosphate binding loop (red). A histidine
implicated in catalysis is also strictly conserved (white on
black).
Sequencing of polymerase chain reaction (PCR) prod-
ucts from our laboratory strain T. brucei S427 revealed
two sequences containing single nucleotide polymor-
phisms (SNPs) that resulted in amino acids differences
compared with the genome sequence of Tb927.6.4430.
A total of 12 clones from three independent PCRs were
sequenced and both sequences were found in equal dis-
tribution, indicating that there is allelic variation in HSK
of diploid T. brucei S427. In sequence 1, asparagine184 is
replaced by serine, while proline325 is replaced by serine
in sequence 2 (red residues in Fig. 2).
Kinetic characterisation of TbHSK
To confirm that T. brucei does indeed encode a bona fide
HSK, the gene from sequence 1 was expressed with an
N-terminal hexa-his tag in Escherichia coli and the recom-
binant protein purified using nickel affinity chromatography.
The protein eluted as two separate peaks with > 95% purity
as judged by sodium dodecyl sulfate – polyacrylamide gel
electrophoresis (SDS-PAGE) (Fig. 3A). The sequence
identity of the two protein peaks was verified by tryptic
mass fingerprinting with 79% sequence coverage (Prot-
eomic and Mass Spectrometry facility, University of
Dundee). The minor contaminating bands were identified
as Escherichia coli proteins, including chaperonins Hsp70
and GroEL; no E. coli HSK was present in an unrelated
recombinant protein purified in a similar fashion, so the
pooled fractions were deemed suitable for kinetic studies
without further purification. Activity was assayed spectro-
photometrically at 340 nm by coupling the formation
of adenosine diphosphate (ADP) to the oxidation of
reduced nicotinamide-adenine dincucleotide (NADH)
using phosphoenolpyruvate, pyruvate kinase and lactate
dehydrogenase. Under these conditions, TbHSK was
Fig. 2. Multiple sequence alignment of HSK from representative species using CLUSTALW. Species abbreviations and NCBI accession
numbers: Mj, Methanococcus jannaschii (Q58504); At, Arabidopsis thaliana (AAD33097); Ec, Escherichia coli (YP_488309); Sc,
Saccharomyces cerevisiae (NP_011890); Tb, Trypanosoma brucei (XP_845560). See text for details on highlighted residues.
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found to phosphorylate L-homoserine, with the rate of
NADH oxidation linear and directly proportional to the
amount of enzyme added (2 to 50 μg ml−1, Fig. 3B), yield-
ing a specific activity of 1.2 U mg−1. The enzyme showed
no activity with other substrates of the GHMP kinase
superfamily (galactose, mevalonate and mevalonate
phosphate) or with D-homoserine. TbHSK was also unable
to phosphorylate other L-amino acids including aspartate,
isoleucine, methionine, serine, threonine and valine. Activ-
ity was not inhibited by these amino acids at concentrations
up to 1 mM. Collectively, these studies confirmed that
TbHSK is a bona fide homoserine kinase and like other
homoserine kinases, is specific for L-homoserine.
TbHSK exhibited a narrow pH profile with optimal activity
at pH 7.5 for L-homoserine (Fig. 3C). The results did not fit
to a classical bell-shaped pH optimum curve (dotted line),
with two inflections above pH7.5. Control experiments
showed that the enzyme is stable at the extremes of pH,
and thus loss of activity was not due to enzyme inactiva-
tion. The double inflections may be due to ionisation of the
substrate homoserine (pKb 9.28) together with an amino
acid residue in HSK, but this was not investigated further.
Nonetheless, the pH optimum profile of TbHSK is in
keeping with the reported T. brucei intracellular pH of 7.4
(Scott et al., 1995). Subsequent characterisation of the
enzyme was therefore carried out at this pH. Under these
quasi-physiological conditions, TbHSK was found to obey
simple Michaelis–Menten kinetics when L-homoserine
concentration was varied in presence of a fixed concentra-
tion of ATP (3 mM) and enzyme (0.7 μM), yielding
a Kmapp of 202 ± 10 μM and kcat of 0.8 s−1 (Fig. 3D). The
catalytic efficiency (kcat/Km = 4 × 103 M−1 s−1) is in good
Fig. 3. Kinetic characterisation of TbHSK.
A. Purity of SDS-PAGE of recombinant TbHSK peaks eluted from the nickel affinity column.
B. Rate of the NADH oxidation over a range of TbHSK concentrations.
C. pH optimum of TbHSK for L-homoserine determined using constant ionic-strength buffers.
D. Kmapp of TbHSK for L-homoserine under quasi-physiological conditions.
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agreement with homoserine kinase from Arabidopsis thali-
ana (2 × 103 M−1 s−1) (Lee and Leustek, 1999), but lower
than E. coli (1.3 × 105 M−1 s−1) (Burr et al., 1976) and
Schizosaccharomyces pombe (2.4 × 104 M−1 s−1) (De
Pascale et al., 2011).
Generation of HSK null mutants
Classical sequential gene replacement was used to inves-
tigate whether this enzyme has a role in the growth or
survival in bloodstream form T. brucei. First, single knock-
out lines resistant to puromycin (SKOPAC) or hygromycin
(SKOHYG) were generated by transfection with the appro-
priate gene replacement construct followed by drug selec-
tion. After cloning, insertion at the HSK locus was
confirmed by Southern blot analysis using a probe that
hybridises with the 3′-UTR (Fig. 4A). Using the same meth-
odology, a line resistant to both puromycin and hygromycin
was obtained following transfection of a cloned SKOPAC line
with a HYG construct (Fig. 4A). Southern blot analysis
using the HSK ORF as a probe confirmed that a double
knockout null mutant (ΔHSK::PAC/ΔHSK::HYG, referred
hereafter as DKO) had been obtained (Fig. 4B). Having
established that the DKO lacked HSK, cells were cultured
in the absence of hygromycin/puromycin for subsequent
experiments. In the absence of drug selection, there was
no difference in doubling times (both 6.3 h) between DKO
and wild-type (WT) cells grown in HMI9T medium.
Growth analyses of bloodstream T. brucei
The ease of generating an HSK null mutant agrees with
the previous genome-wide study using RNAi (Alsford
et al., 2011) that HSK is non-essential for parasite survival
when grown in rich medium in vitro. However, as previ-
ously discussed (Ong et al., 2013), components of HMI9T
may serve as a bypass for loss of de novo biosynthesis,
making this medium unsuitable for studying more subtle
metabolic requirements. In particular, the high concentra-
tion of threonine in HMI9T (800 μM) would negate any
requirement for de novo threonine biosynthesis. With this
in mind, parasites were sub-cultured into a threonine-free
medium (TBMTD) to determine if cells required threonine
supplementation for growth. WT cells continued to grow
robustly in TBMTD supplemented with 800 μM threonine
with a small, but significant (P < 0.0001), decrease in dou-
bling time (7.86 ± 0.09 h) compared with cells cultured in
HMI9T (6.68 ± 0.04 h). WT cells were unable to grow at all
in the absence of threonine with cells perishing by day 4
following subculture (Fig. 5A). DKO parasites grew
exactly like WT cells, with the same doubling time and
also perished by day 4 without threonine supplementation
(Fig. 5A). There was no difference in threonine require-
ment between these cells (Fig. 5B), with threonine con-
centrations required for 50% of maximal growth (GC50) of
6.2 ± 0.9 and 6.4 ± 1.3 μM for WT and DKO cells respec-
tively. Because the medium contains 200 μM aspartate,
these findings suggest that bloodstream T. brucei is either
Fig. 4. Genotypic analysis of WT, SKO and DKO cell lines. Southern blot analysis of AatII-digested genomic DNA (∼5 μg) from diploid
wild-type trypanosomes (WT), ΔHSK::HYG (SKOHYG); ΔHSK::PAC (SKOPAC); and ΔHSK::HYG/ΔHSK::PAC (DKO) using a probe against the
3′-UTR of HSK (panel A) or the open reading frame of HSK (panel B). A schematic representation of the HSK locus and its gene
replacements is shown to the right of the blot.
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unable to synthesise threonine from aspartate or that the
rate of de novo synthesis pathway is insufficient to meet
threonine requirements. In A. thaliana, threonine biosyn-
thesis is limited by the rate of homoserine formation from
aspartate (Lee et al., 2005). To examine whether this
was also the case for bloodstream T. brucei, cultures in
TBMTD were supplemented with varying concentrations of
L-homoserine. Unexpectedly, neither WT nor DKO cells
were able to utilise L-homoserine for growth, over a wide
range of concentrations (0.4 μM to 10 mM). These results
indicate that bloodstream form T. brucei is incapable of
salvaging/utilising homoserine sufficiently to meet the
metabolic demand for threonine.
To assess whether HSK is required for virulence, as in
the case of C. albicans and Saccharomyces cerevisiae
(Kingsbury and McCusker, 2010a), the infectivity of DKO
cells was determined in our animal model of infection.
DKO parasites were as infectious as WT cells, with all
animals reaching terminal parasitaemia by day 4 of the
study. This indicates that the threonine concentration in
mouse blood is sufficient to support parasite growth, in
agreement with a previous study (Mazet et al., 2013).
HSK is therefore a non-essential enzyme in bloodstream
T. brucei both in vitro and in vivo.
Procyclic form T. brucei can utilise homoserine and
homoserine lactones for growth
The absence of any phenotype in bloodstream forms
prompted us to search for a function in the insect
stage (procyclic forms) of the T. brucei life cycle. WT
and DKO bloodstream forms were differentiated to their
respective procyclic forms using an established protocol,
as described in the methods. Both cell types grew slug-
gishly for an initial 30 days (doubling times ranging from 33
to 110 h) before rapidly growing cultures were obtained.
Subsequent growth analyses were carried out on these
established lines. After the initial 30 day adaptation, both
WT and DKO parasites continued to grow robustly when
sub-cultured in DTMTD plus 400 μM threonine with dou-
bling times of 16.8 ± 0.1 h (Fig. 6A). Both cell types were
unable to grow without threonine supplementation, with
cell death commencing after 3 days. WT and DKO procy-
clics had similar requirements for L-threonine (Fig. 6B),
with GC50 values about five times higher than the blood-
stream forms (Table 1). Non-physiological concentrations
of threonine (> 1 mM) inhibited growth of both cell lines.
However, in marked contrast to bloodstream forms, WT
procyclics were able to utilise L-homoserine in place of
threonine for growth, while DKO parasites were unable to
do so (Fig. 6C). Maximal growth was obtained for WT
procyclics at 50 μM homoserine, with higher concentra-
tions inhibiting growth. While having a marginal (∼ fourfold)
preference for L-homoserine over L-threonine, WT procy-
clics were also ∼ 70-fold more susceptible to growth inhi-
bition by L-homoserine versus L-threonine based upon
GC50 and EC50 values (Table 1). These results establish a
role for HSK in the insect stage of the T. brucei life cycle.
Because DTMTD contains only 100 μM L-aspartate, we
tested whether L-aspartate availability was rate limiting for
homoserine production. However, WT procyclics were
unable to grow in the absence of either L-threonine or
L-homoserine, even in the presence of 1 mM L-aspartate.
In addition, [3H]-aspartate (100 μCi ml−1; 8.3 μM)
Fig. 5. Growth analyses of bloodstream WT and DKO cells in vitro.
A. WT (circles) and DKO (squares) cells cultured in TBMTD with (open symbols) or without (closed symbols) 800 μM threonine. No viable cells
visible after 4 days ( ).
B. Growth of WT (open circles) and DKO (closed circles) cells in varying concentrations of L-threonine.
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was neither taken up by T. brucei nor incorporated into
macromolecules when incubated in an aspartate and
threonine-deficient DTM (DTMATD). As such, it is doubtful
that T. brucei can synthesise homoserine de novo.
In stark contrast, Leishmania donovani promastigotes
were able to grow in DTMATD without any threonine or
aspartate supplementation (Fig. 7). Growth was unaf-
fected by the addition of L-aspartate (100 μM), while dou-
bling time was marginally, but significantly (P < 0.0001),
reduced from 8.66 ± 0.07 to 7.92 ± 0.05 h when L-
threonine (400 μM) was added. Moreover, when incu-
bated with [3H]-aspartate in DTMATD as above, [3H]-label
was readily detected in both supernatant and pellet
extracts of L. donovani. Thus, L. donovani appears to
have a fully functional β-aspartyl phosphate pathway as
reported for L. mexicana (Saunders et al., 2011).
These findings raise a key question: what are the poten-
tially salvageable sources of homoserine in tsetse flies?
Male and female tsetse feed exclusively on blood (Jordan,
1993), and females are viviparous, raising a single larva in
utero which is fed by a milk secretion rich in protein and
lipids (Cmelik et al., 1969). Mammalian blood does not
Fig. 6. Growth analyses of procyclic WT and DKO cells in vitro.
A. The cumulative growth curves of WT (open circles) and DKO (closed circles) cells cultured in DTMTD supplemented with 400-μM threonine
were determined over 2 weeks. WT (open squares) and DKO (closed squares) cells perished on day 6 in the absence of L-threonine ( ).
B. Growth of WT (open circles) and DKO (closed circles) cells in varying concentrations of threonine.
C. Growth of WT (open circles) and DKO (closed circles) cells in varying concentrations of L-homoserine.
D. Growth of WT cells in varying concentrations of L-homoserine lactone (open circles); N-3-oxododecanoyl-L-homoserine lactone (closed
circles); N-3-oxodecanoyl-L-homoserine lactone (open squares); and N-3-oxohexanoyl-L-homoserine lactone (closed squares). DKO cells
failed to grow with any of these supplements.
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contain homoserine under normal physiological condi-
tions, so this cannot be the source (Gazarian et al., 2002).
Moreover, the tsetse genome lacks any genes involved
in the threonine de novo biosynthesis (International
Glossina Genome Initiative, 2014), so the fly itself cannot
be the source either. However, tsetse microbiota includes
two enteric Gammaproteobacteria, the obligate mutualist
Wigglesworthia glossinidia and the commensal Sodalis
glossinidius. An analysis of the genome of S. glossinidius
suggests that this bacterium is capable of synthesising all
amino acids, except for alanine (Toh et al., 2006), whereas
W. glossinidia has a reduced capacity (Akman et al.,
2002). BLAST searches using the threonine biosynthetic
pathway enzymes from E. coli identified credible candi-
dates (66–80% identity) for all enzymes in the pathway
in the S. glossinidius genome, but not in W. glossinidia.
The latter lacks HSK and ThrS, but retains the rest of
the pathway for peptidoglycan biosynthesis. The first
enzyme in the pathway is a bifunctional aspartokinase-
homoserine dehydrogenase, so should also synthesise
homoserine. Whether these bacteria can excrete homo-
serine is not known. A second potential source of homo-
serine could be acyl homoserine lactones (AHLs),
which are secreted by many bacteria for intra- and inter-
species communication (Waters and Bassler, 2005). For
example, the quorum sensing system in S. glossinidius
uses N-(3-oxohexanoyl) homoserine lactone (3OC6HSL)
to modulate gene expression in response to bacterial
cell density and to oxidative stress (Pontes et al., 2008).
Accordingly, several commercially available AHLs were
tested for their ability to support growth of T. brucei in the
absence of threonine (Fig. 6D, Table 1). Homoserine
lactone and all five AHLs supported growth of WT procy-
clics to varying degrees, with homoserine lactone > N-3-
oxododecanoyl-L-homoserine lactone (3OC12HSL) >
N-3-oxodecanoyl-L-homoserine lactone (3OC10HSL) > N-
3-oxohexanoyl-L-homoserine lactone (3OC6HSL) > N-3-
butyryl-DL-homoserine lactone (3C4HSL). In contrast,
DKO parasites were completely unable to utilise any of
these homoserine lactones for growth.
Discussion
Our study highlights a potentially important role for HSK in
the insect stage of the T. brucei life cycle under conditions
of threonine starvation. Threonine is an important source of
acetyl CoA in procyclic T. brucei, yet most threonine is
metabolised and excreted as glycine and acetate to no
apparent purpose, except perhaps for the energy-
generating potential of the oxidation step (Cross et al.,
1975). These authors noted that L-threonine was the sole
amino acid to be severely depleted in spent procyclic
Table 1. Comparison of ability of different amino acids and homoserine lactones to support and inhibit growth in procyclic form Trypanosoma
brucei.
GC50 (μM) EC50 (μM)
WT DKO WT DKO
L-threonine 36.5 ± 1.9 40.1 ± 5.0 7760 ± 740 7200 ± 520
L-homoserine 9.6 ± 0.58 > 50 000a 96 ± 7.3 –
L-homoserine lactone 14.4 ± 0.9 > 25 000a 113 ± 8 –
N-3-oxododecanoyl-L-homoserine lactone 107 ± 2 > 500a 237 ± 5 –
N-3-oxodecanoyl-L-homoserine lactone 619 ± 40 > 500a – –
N-3-oxooctanoyl-L-homoserine lactone > 1250b > 1250a – –
N-3-oxohexanoyl-L-homoserine lactone 6970 ± 520 > 5000a – –
N-3-butyryl-D,L-homoserine lactone 7100 ± 300 > 25 000a – –
Results are means ± SEM of triplicate measurements.
a. No growth observed at maximum concentration tested.
b. Fifteen per cent growth observed at solubility limit.
Fig. 7. Growth of Leishmania donovani promastigotes cultured in
medium lacking aspartate and threonine. Cumulative growth curves
were determined over 14 days with subculture into fresh medium
every 2 days. No additions (open circles); plus 100 μM L-aspartate
(closed circles); plus 400 μM L-threonine (closed squares); plus
100 μM L-aspartate and 400 μM L-threonine (open squares).
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culture medium. Our amino acid analyses of spent medium
confirmed this: after 72 h of culture, we were unable to
detect any threonine in our medium. Subsequent studies
by others have shown that threonine is indeed the pre-
ferred source of acetate for incorporation into fatty acids
and sterols, and that ATP is generated from acetyl CoA via
the concerted action of the mitochondrial acetate : succi-
nate CoA transferase/succinyl CoA synthetase cycle, as
well as from NADH (Millerioux et al., 2013).
To confirm the existence of the pathway from homoser-
ine to threonine, we have demonstrated that Tb927.6.4430
encodes a protein with homoserine kinase activity, with
properties similar to homoserine kinases from other organ-
isms (Theze et al., 1974; Lee and Leustek, 1999; De
Pascale et al., 2011). The T. brucei enzyme behaves
more like A. thaliana HSK, and, unlike HSK from E. coli
and S. cerevisiae, is not inhibited by L-threonine or
L-homoserine (Theze et al., 1974; Ramos et al., 1991; Lee
and Leustek, 1999). Although HSK is expressed in both
stages of the T. brucei life cycle (Urbaniak et al., 2012),
nutritional and gene deletion experiments reveal that HSK
is not essential for survival or virulence in the clinically
relevant mammalian stage, and therefore is not a drug
target, unlike in certain fungal pathogens (Kingsbury and
McCusker, 2008; 2010a,b).
In contrast to the bloodstream form, HSK does have a
potential role to play under conditions of threonine star-
vation in procyclic form T. brucei. Homoserine, homoser-
ine lactone and AHLs were all able to support growth in
WT trypanosomes to varying degrees. The fact that none
of these metabolites could support growth in HSK null
mutants suggests that AHLs must first be degraded to
L-homoserine prior to conversion to threonine. The pos-
sible carboxypeptidases, acylases or lactonases catalys-
ing this conversion are unknown.
Precise information on the availability of threonine or
homoserine in the midgut of the tsetse fly, where the
procyclic stage resides, is not available. Tsetse flies are
obligate blood feeders and undergo cyclical periods of
starvation and feeding every 2–5 days –‘the hunger cycle’.
Homoserine is not present in blood, so the initial major
source of dietary threonine is from haemoglobin or plasma.
The haemoglobin concentration in adult human blood is
∼ 2.5 mM. The protein is an α2β2 tetramer with nine and
seven threonine residues per α and β monomers respec-
tively. Thus, haemoglobin contributes ∼ 80 mM threonine
to the blood meal, with threonine in plasma making a minor
contribution (0.2–0.7 mM). A similar calculation for proline,
a major source of energy for procyclic trypanosomes,
yields 70 mM (haemoglobin) and ∼ 0.2 mM (plasma).
However, though these sources appear considerable, it
should be noted that digestion of the blood meal is com-
plete by 72h and thus trypanosomes are likely to be under
nutritional stress thereafter.
Comparative genomics suggests a remarkable meta-
bolic interdependence between the tsetse fly and its
microbiota, S. glossinidius and W. glossinidia. (Some
populations also harbour Wolbachia which is not consid-
ered further in this context as it is localised exclusively
intracellularly in germline tissues and not the insect gut.)
In the case of the obligate symbiont, W. glossinidia,
despite extensive diminution in its metabolic capabilities,
this bacterium has retained the capacity to synthesise
cofactors and vitamins (Akman et al., 2002). Female flies
lacking W. glossinidia are sterile, but fertility can be par-
tially restored by supplementing artificial blood meals with
B-complex vitamins, suggesting that these vitamins are
supplied by Wigglesworthia. W. glossinidia reside intracel-
lularly in host epithelial cells (bacteriocytes), which form an
organ, the bacteriome, in the anterior mid-gut (Wang et al.,
2013). W. glossinidia has retained the ability to convert
aspartate to diaminopimelate for the synthesis of peptido-
glycan, possibly for protection from the host environment
during transmission via the milk secretion to the intrauter-
ine larva. Although predicted to be no longer capable
of synthesising threonine, retention of the bifunctional
aspartokinase-homoserine dehydrogenase suggests that
homoserine may be present as an unwanted intermediate
of peptidoglycan biosynthesis (Fig. 8). However, evidence
is lacking on whether the homoserine dehydrogenase
domain of this protein is still enzymatically active. More-
over, cultivation of W. glossinidia in vitro has proved
impossible to date, so little is known about its metabolic
end-products.
The mutualist endosymbiont, S. glossinidius, is widely
distributed in tsetse tissues, including the midgut and milk
secretions. In contrast to W. glossinidia, S. glossinidius
has retained the ability to synthesise diaminopimelate, as
well as threonine (Fig. 8), in addition to all other protein
amino acids, except alanine (Toh et al., 2006). Interest-
ingly, S. glossinidius is also predicted to possess a putative
threonine export protein (Toh et al., 2006). This appears
similar to the situation in E. coli (RhtA, RhtB and RhtC) and
Corynebacterium glutamicum (ThrE) used for the commer-
cial production of this essential amino acid (Dong et al.,
2011). Of these permeases, only RhtA is reported to
efflux both L-threonine and L-homoserine (Dong et al.,
2011). However, the putative export function and amino
acid specificity of the S. glossinidius permease has not
been studied. Another potential source of homoserine is
the quorum-sensing AHL N-3-oxohexanoyl homoserine
lactone secreted by Sodalis (Pontes et al., 2008). Unfortu-
nately, the concentration of this AHL was not reported by
the authors, so it is difficult to assess the potential nutri-
tional role of this secondary metabolite. This would involve
knowledge of the bacterial load, the rate of synthesis,
diffusion and degradation of AHL in the tsetse. Very few
publications report the concentrations of AHLs in other
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bacterial systems and those that do vary widely: ∼ 0.1 μM
for Vibrio fischeri in symbiotic squid light organs (Boettcher
and Ruby, 1995), 16 μM in stationary phase Agrobacte-
rium tumefaciens (Zhu et al., 1998) and > 600 μM in Pseu-
domonas aeruginosa biofilms (Charlton et al., 2000).
However, indirect evidence can be drawn from studies on
S. glossinidius-free flies obtained by treatment with strep-
tozotocin, an antibiotic that had no effect on Wiggleswor-
thia. These flies showed a deceased longevity, with no loss
in fertility, but became significantly more resistant to trypa-
nosome infections (Dale and Welburn, 2001). Although the
authors attributed this effect to the bacterium’s chitinolytic
activity, it is also possible that this could be attributed to loss
of a source of homoserine.
In conclusion, our findings indicate that L-homoserine
or AHLs can substitute for the essential amino acid
L-threonine in procyclic forms of T. brucei. Although bio-
chemical evidence for the source of these precursors is
lacking, bioinformatic analysis of the tsetse fly endosym-
bionts suggests a number of plausible sources. Our
hypothesis offers an explanation for the trypanosome
retaining a partial pathway, in contrast to the leishmania
parasite that retains the complete pathway. Further work
is needed to test which of these hypotheses is correct.
Experimental procedures
Organisms and reagents
Chemicals and reagents used in this study were of
the highest grade and purity available. L-homoserine,
L-homoserine lactone dihydrochloride and all AHLs were
purchased from Sigma Aldrich. T. brucei bloodstream form
‘single marker’S427 (T7RPOL TETR NEO) was cultured at
37°C in HMI9T (Greig et al., 2009), supplemented with
2.5 μg ml−1 G418 (Geneticin, Invitrogen). L. donovani pro-
mastigote cell line LdBOB (derived from MHOM/SD/62/1S-
CL2D) was grown in M199 plus supplements (Goyard
et al., 2003) at 28°C. Threonine-deficient trypanosome
base media (TBMTD) was prepared as described for TBM
(Ong et al., 2013), with threonine excluded from the
Iscove’s modified Dulbecco’s MEM component and sup-
plemented with 10% dialysed bovine foetal calf serum
(PAA Laboratories). Threonine-deficient differentiation
medium (DTMTD) is based on DTM (Ziegelbauer et al.,
1990) and was prepared by excluding threonine from the
MEM essential amino acids solution formulation and
replacing normal FCS with 15% dialysed bovine FCS. Cell
densities were determined using the CASY TT cell counter
(Schärfe).
Generation of protein expression and
knockout constructs
PCR primers were designed using the T. brucei HSK
sequence in GeneDB (Tb927.6.4430) as a template to
generate constructs for protein expression and genetic
manipulation (Table S1). The HSK open reading frame
(ORF) was PCR-amplified from T. brucei genomic
DNA using ORF/XhoI_s and ORF/BamHI_as primers
(Table S1) and Pfu polymerase. The resulting ∼ 1 kb PCR
Fig. 8. Enzymes predicted by bioinformatic analysis to be present in Sodalis glossinidius, Wigglesworthia glossinidia and Trypanosoma
brucei. Key end-products of metabolism are boxed and excreted metabolites boxed and shaded. See legend for further details.
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product was cloned into the Zero Blunt®TOPO shuttle
vector (Life Technologies), before subcloning into the
E. coli expression vector pET15b modified to include a
tobacco etch virus protease cleavage site for recombinant
protein expression. The 5′- and 3′-untranslated regions
(UTRs) of HSK were similarly PCR-amplified from T. brucei
genomic DNA using gene knockout primers (5′UTR/
NotI_s, 5′UTR/HindIII_as, 3′UTR/BamHI_s and 3′UTR/
NotI_as; Table S1) and Pfu polymerase. The amplified
regions were used to assemble the replacement cassettes
containing the selectable drug resistance genes puromy-
cin N-acetyl transferase (PAC) and hygromycin phospho-
transferase (HYG), exactly as previously described (Martin
and Smith, 2005). All constructs were confirmed by DNA
sequencing (www.dnaseq.co.uk).
Recombinant expression and purification of TbHSK
Recombinant TbHSK was expressed in E. coli strain
ArcticExpress (DE3) RP (Agilent Technologies). Trans-
formed cells were cultured in autoinduction medium plus
100 μg ml−1 ampicillin at 37°C with shaking at 200 r.p.m.
until OD 0.8–1.0 was achieved. Cultures were further
incubated for 72 h at 12.5°C, with shaking at 200 r.p.m.
before cells were harvested by centrifugation (3000 g,
20 min, 4°C). Cells were resuspended in lysis buffer
(50 mM Tris-HCl and 200 mM NaCl, pH 7.5) supple-
mented with ethylenediaminetetraacetic-acid-free com-
plete protease inhibitor cocktail (Roche) and lysed using a
continuous cell disruptor (Constant Systems) at 30 000
Psi. Lysates were clarified by centrifugation (40 000 g,
30 min, 4°C) and recombinant proteins purified using
nickel affinity chromatography. Supernatants were applied
to a 5 ml Ni2+ column (GE Healthcare), pre-equilibrated in
lysis buffer and connected to an AKTA™ FPLC purifier.
Bound proteins were eluted using a gradient of 0–100%
1M imidazole in lysis buffer and analysed by SDS-PAGE
using a NuPAGE Novex 4–12% Bis-Tris gel (Life Tech-
nologies). Proteins were visualised and purity assessed
by Coomassie Brilliant Blue staining.
Enzyme kinetics
The activity of recombinant TbHSK was determined using
a previously described spectrophotometric assay (Lee
and Leustek, 1999) on a UV-1601 spectrophotometer
(Shimadzu). TbHSK was pre-equilibrated with 0.25 mM
NADH, 1.2 mM phosphoenolpyruvate, 3 mM ATP, 10 mM
MgSO4 and the coupling enzymes [pyruvate kinase (10 U)
and lactate dehydrogenase (15 U), Sigma Aldrich] for
1 min at 25°C. Enzymatic reactions were initiated by the
addition of L-homoserine. Initial rates of NADH oxidation
was measured for 120 s at 340 nm and converted to
molar units using the extinction coefficient 6.22 mM cm−1.
One unit of enzyme activity is defined as one micromole of
substrate used per minute. Except for pH optimum deter-
mination, all enzymatic assays were carried out in 50 mM
HEPES buffer, adjusted to pH 7.4 and an ionic strength of
100 mM using KOH and KCl. The pH optimum of TbHSK
(0.7 μM) for L-homoserine (3000 μM) was determined
using constant ionic strength overlapping buffers as pre-
viously described (Ong et al., 2011). The Kmapp of TbHSK
for L-homoserine was determined by measuring the
activities of a fixed enzyme concentration (0.7 μM) in the
presence of varying concentrations of L-homoserine
(23–3000 μM). The results were analysed using GraFit
and fitted to the Michaelis–Menten equation.
Generation of T. brucei transgenic mutants
Knockout plasmids were linearised using NotI, precipitated
with ethanol and resuspended in sterile water (1 μg ml−1).
Wild-type T. brucei (4 × 107 cells) were harvested and
resuspended in reagents from the Human T cell Nucleo-
fector kit, as per manufacturers’ instructions. Linearised
DNA (5 μg) were added and cells were electroporated
using programme X-001 of the Nucleofector II electropo-
rator (Amaxa) (Burkard et al., 2007). A single knockout cell
line of HSK (SKOHYG) was first generated by replacing the
first allele with the HYG gene. SKOHYG parasites were
selected by culturing in the continuous presence of hygro-
mycin (4 μg ml−1). SKOPAC parasites were prepared in a
similar fashion using 0.1 μg ml−1 puromycin for selection.
The remaining HSK allele in an established SKOHYG clone
was subsequently replaced by transfection with the PAC
construct and selection with hygromycin and puromycin in
order to generate a DKO cell line. DKO parasites were
selected by culturing in the continuous presence of both
hygromycin and puromycin. Transfected parasites were
cloned by limiting dilution at each respective stage.
Southern blot analysis
Digoxigenin-labeled 3′-UTR of T. brucei HSK was gener-
ated by PCR amplification (with primers previously
described for generating knockout constructs) using the
PCR DIG Probe Synthesis Kit (Roche) as per manufactur-
er’s instructions. Using the resulting product as a probe,
Southern analysis of genomic DNA (5 μg) samples
digested with the restriction endonuclease AatII was
carried out exactly as previously described (Wyllie et al.,
2009).
In vivo studies
All animal experiments were subject to local ethical review
and performed under the Animals (Scientific Procedures)
Act 1986 in accordance with the European Communities
Homoserine kinase and threonine biosynthesis 153
© 2014 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 95, 143–156
Council Directive (86/609/EEC). Groups of five mice were
infected by intraperitoneal injection (104 parasites), with
bloodstream-form T. brucei cultured in HMI9T. Infections
and parasitaemia were monitored as previously described
(Sienkiewicz et al., 2008), with animals reaching a
terminal parasitaemia (> 108 cells ml−1) euthanized and
recorded as dead on the same day.
Differentiation of bloodstream T. brucei to procyclic form
Differentiation of bloodstream T. brucei to procyclic form
was carried out as previously described (Ziegelbauer
et al., 1990), with minor modification. Bloodstream form
T. brucei cultured in HMI9T were harvested, washed
once and resuspended (3 × 106 cells ml−1) in DTMTD plus
400 μM threonine and CCA (3 mM sodium citrate + 3 mM
sodium cis-aconitate). Cultures were incubated at
28°C with cell densities maintained between 1 × 106 and
8 × 106 ml−1. Rapidly growing differentiated cells were
established in DTMTD plus 400 μM threonine after 30 days
(CCA excluded after day 7) before further analyses.
Ability of T. brucei to utilise threonine, homoserine and
homoserine lactones for growth
The ability of threonine, homoserine and homoserine lac-
tones to support the growth of bloodstream and procyclic
forms of T. brucei were investigated in TBMTD and DTMTD
respectively. Concentrations required to support growth
were determined in 96-well microtitre plates in a final
culture volume of 200 μl per well and an initial parasite
seeding density of 2.5 × 103 cells ml−1 (bloodstream) or
5 × 105 cells ml−1 (procyclics). Stock solutions of threo-
nine, L-homoserine, L-homoserine lactone and N-butyryl-
D,L-homoserine lactone were prepared in water, while
other AHLs were dissolved in dimethylsulfoxide. Appropri-
ate amounts of solvent were added in control samples.
Cultures were incubated for 48 h (procyclic form) or 72 h
(bloodstream form) before cell densities were determined
using a resazurin-based assay (Jones et al., 2010).
Growth is expressed as a percentage of maximum growth
relative to the same cell line grown in the presence of
400 μM (procyclic form) or 800 μM L-threonine (blood-
stream form). These threonine concentrations correspond
to the original levels present in DTM and TBM. The con-
centration of supplement required to support 50%
maximum cell growth (GC50) was determined by plotting
cell density versus amino acid concentration and ana-
lysed by 2-parameter non-linear regression using GraFit.
Radiolabelling studies
Trypanosoma brucei procyclics and L. donovani promas-
tigotes were harvested by centrifugation (800 g, 10 min,
4°C) and resuspended (1 × 107 cells ml−1) in fresh DTMATD
or transport buffer (Ali et al., 2013) containing-L- [2,3-3H]-
aspartate (Perkin Elmer, final concentration 8.3 μM,
100 μCi ml−1). Cells were harvested by centrifugation after
1, 2, 4, 24 h and washed twice with transport buffer. The
resulting cell pellets were heat treated with dabsyl chlo-
ride to derivatise the amino acids as previously described
(Sethuraman et al., 2004). Samples were centrifuged
(16 000 g, 10 min, 22°C) and 0.02 ml of the resulting
supernatants was added to 1 ml of scintillation fluid.
Pellets were solubilised in 0.1 ml 0.1 M NaOH and mixed
with 1 ml scintillation fluid. Radioactivity was then deter-
mined using a Beckman scintillation counter.
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